| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/11/1995 | EP0632725A1 Alkylthio alkyl avermectins are active antiparasitic agents |
| 01/11/1995 | EP0632724A1 Phenol and pyridinol derivatives as lusitropic agents |
| 01/11/1995 | EP0632723A1 Use of transglutaminase inhibitor for the treatment of scar tissue |
| 01/11/1995 | EP0632721A1 Sustained release composition and method utilizing xanthan gum and an active ingredient |
| 01/11/1995 | EP0632717A1 Agent for use as an anti-irritant |
| 01/11/1995 | EP0552227B1 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation |
| 01/11/1995 | EP0544821B1 Indole derivatives as antiallergy and antiinflammatory agents |
| 01/11/1995 | EP0544696B1 Hypoglycemic hydroxyurea derivatives |
| 01/11/1995 | EP0362288B1 Expression of immunologically active proteins of human b-lymphotropic virus |
| 01/11/1995 | EP0362279B1 Saponin adjuvant |
| 01/11/1995 | EP0324745B1 Topical agents containing prostacycline derivatives |
| 01/11/1995 | EP0301034B1 Use of 1-(3'trifluoromethyl 4'-nitrophenyl) 4,4-dimethyl imidazoline 2, 5-dione in the manufacture of a medicament for the treatment of hormone-dependent cancers other than cancers of the prostate, the skin and the colon |
| 01/11/1995 | CN1097195A Synthesizing technology for Antai growth promotor |
| 01/11/1995 | CN1097194A Dammarane-type saponin ginseng lowhydric alcohol derivative and preparation method |
| 01/11/1995 | CN1097192A Retroviral protease inhibitors |
| 01/11/1995 | CN1097135A Slim jianfeibao (a drug capable of reducing fat) |
| 01/11/1995 | CN1027373C Therapeutic nucleosides |
| 01/11/1995 | CN1027371C Synthetizing method for inner ester diterpenoid |
| 01/11/1995 | CN1027370C Process for production of thiazole derivatives |
| 01/11/1995 | CN1027369C Excitatory amino acid antagonists |
| 01/11/1995 | CN1027368C Process for preparing substituted quinoline derivatives |
| 01/11/1995 | CN1027341C N-phenylpyrazole derivatives |
| 01/10/1995 | US5380947 Catalyst supports or drugs with quaternary ammonium compounds |
| 01/10/1995 | US5380937 Derivatives of 4-hydroxybutyric acid |
| 01/10/1995 | US5380927 Process for preparing optically active 2-aryl-alkanoic acids, in particular 2-aryl-propionic acids |
| 01/10/1995 | US5380922 Benzenedimethanol suitable for micronisation |
| 01/10/1995 | US5380921 Aminophosponic acid derivative |
| 01/10/1995 | US5380897 Tri(platinum) complexes |
| 01/10/1995 | US5380888 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 01/10/1995 | US5380879 Immunosuppressants |
| 01/10/1995 | US5380878 Racemization, cognition activator |
| 01/10/1995 | US5380874 Pyrrolidine carbamates |
| 01/10/1995 | US5380866 Alkyl substituted nitroimidazole acetic acids |
| 01/10/1995 | US5380858 Process for the preparation of intermediates useful for the synthesis of histamine receptor antagonists |
| 01/10/1995 | US5380856 Process for preparation of a polymorphic form of terphenadine having a high melting point and enhanced purity, and the product thus obtained |
| 01/10/1995 | US5380851 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation |
| 01/10/1995 | US5380850 (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes |
| 01/10/1995 | US5380847 Synthesis of certain 1-(1-methylpiperidin-4-y1)-3-phenylpyrazolo[4,3-C]pyridines |
| 01/10/1995 | US5380838 In alcohol, parasiticide, anthelmintic |
| 01/10/1995 | US5380837 Alpha-methyldopa or its salt with D-glucose residues attached in alpha fashion to either or both hydroxyls; pharmaceutical compositions |
| 01/10/1995 | US5380832 Ganglioside GM3 analogs |
| 01/10/1995 | US5380829 Thioglycoside analogs of gangliosides |
| 01/10/1995 | US5380765 Chemosensory olfactory assay for psychiatric disorders |
| 01/10/1995 | US5380763 Applying 1-pentadecanol |
| 01/10/1995 | US5380761 Transdermal compositions |
| 01/10/1995 | US5380760 Polyisobutylene adhesive |
| 01/10/1995 | US5380759 Methyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2-zyl]carbamate used to treat leukemia |
| 01/10/1995 | US5380757 Method of treating vulvar dystrophy and vaginal dryness |
| 01/10/1995 | US5380756 Fatty acid monoester of glycerol |
| 01/10/1995 | US5380754 Topical composition enhancing healing of viral lesions |
| 01/10/1995 | US5380752 Method for preventing oxidation of crystalline steroid alcohols in cells, lipoproteins, and chylomicrons |
| 01/10/1995 | US5380751 6,7-modified paclitaxels |
| 01/10/1995 | US5380750 Arylethylamine compounds |
| 01/10/1995 | US5380749 Thioxanthenone antitumor agents |
| 01/10/1995 | US5380747 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 01/10/1995 | US5380745 Medicinal composition |
| 01/10/1995 | US5380742 4H-thieno[3,4-c]pyrrole derivatives |
| 01/10/1995 | US5380739 Substituted indole derivatives |
| 01/10/1995 | US5380738 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
| 01/10/1995 | US5380736 Cholecystokinin and gastric antagonist |
| 01/10/1995 | US5380735 Benzothiazole derivatives and methods of use |
| 01/10/1995 | US5380731 Piperidinyl benzimidazoles as antagonist of histamine H1 |
| 01/10/1995 | US5380730 Pyridine compounds which have useful pharmaceutical utility |
| 01/10/1995 | US5380729 12-hetero substituted 6,11-ethano-6,11-dihydrobenzo (b) quinolizinium salts and compositions and method of use thereof |
| 01/10/1995 | US5380727 Synergistic combination for treating herpes infections |
| 01/10/1995 | US5380726 Interleukin inhibitors |
| 01/10/1995 | US5380724 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 01/10/1995 | US5380723 Indole derivatives |
| 01/10/1995 | US5380717 Food composite for performing function of large bowel regulation |
| 01/10/1995 | US5380716 Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation |
| 01/10/1995 | US5380715 Ap4 A as a hypotensive agent |
| 01/10/1995 | US5380714 2-furyl-triazalo [1,5-a]-[1,3,5]triazines and pyrazolo [2,3-a][1,3,5]triazines |
| 01/10/1995 | US5380713 Serine protease inhibitors |
| 01/10/1995 | US5380711 Methods for delipidation of skin and cerumen removal |
| 01/10/1995 | US5380533 Gastroresistant pharmaceutical formulations for oral administration containing bile acids |
| 01/10/1995 | US5380531 C-terminal substituted |
| 01/10/1995 | US5380523 High energy coprecipitate of nonoxynol oligomer, PVP and iodine having contraceptive and potent anti-HIV properties |
| 01/10/1995 | US5380522 Method for treatment of irritable bowel syndrome |
| 01/10/1995 | EP0639186A4 Taxol derivatives. |
| 01/10/1995 | CA2126513A1 Chondroprotective agents |
| 01/10/1995 | CA2126512A1 Chondroprotective agents |
| 01/10/1995 | CA2117399A1 Topically administrable zinc phthalocyanine compositions |
| 01/10/1995 | CA1333911C Dicarboxylic acid-bis(3,5-dicarbamoyl-2,4,6- triiodoanilides), process for their production as well as x-ray contrast media containing them |
| 01/10/1995 | CA1333906C Cycloalkylthiazole derivatives |
| 01/10/1995 | CA1333905C Branched-chain alkyl esters of 2-[4-(2-piperidino-ethoxy) -benzoyl]-benzoic acid, processes for their preparation and their use as spasmolytic agents |
| 01/10/1995 | CA1333884C Phosphorous binder |
| 01/10/1995 | CA1333852C Moulding contact lenses |
| 01/09/1995 | WO1995001958A1 Difluoro statone analogs |
| 01/08/1995 | CA2127519A1 Pharmaceutical composition useful for treating ophthalmological diseases |
| 01/06/1995 | CA2127218A1 Compositions for the treatment of inflammatory proliferative skin disease and their use |
| 01/05/1995 | WO1995000848A1 Compositions and methods for anti-addictive narcotic analgesis acivity screening and treatments |
| 01/05/1995 | WO1995000844A1 Novel clinical marker and therapeutic agent in kidney stone disease and methods of use |
| 01/05/1995 | WO1995000654A1 Mesothelial cell gene therapy |
| 01/05/1995 | WO1995000649A1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy |
| 01/05/1995 | WO1995000638A2 Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
| 01/05/1995 | WO1995000613A1 Cleaning and disinfecting agent |
| 01/05/1995 | WO1995000532A1 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof |
| 01/05/1995 | WO1995000531A1 NOVEL PROCESS FOR PREPARING 17β-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES |
| 01/05/1995 | WO1995000527A1 Fucosylated glycosides as inhibitors of bacterial adherence |
| 01/05/1995 | WO1995000522A1 Phosphosuccinic acid derivatives and their use as medicaments |